Description
GC376 is an inhibitor of the main protease M
pro (3CL
pro) in coronaviruses as well as picornaviruses. This broad-spectrum antiviral compound has been used as investigational veterinary drug for treatment of feline infectious peritonitis virus (FIPV) infections. Recent studies also showed that GC376 inhibits the main protease M
pro (3CL
pro) from SARS-CoV-2 with IC
50 of 0.03 μM and EC
50 of 3.37 μM.
References
[1] Kim, Yunjeong, et al. “Broad-Spectrum Antivirals against 3C or 3C-like Proteases of Picornaviruses, Noroviruses, and Coronaviruses.”
Journal of Virology, 86 21, 2012, pp. 11754–62,
https://doi.org/10.1128/JVI.01348-12.
[2] Lu, Jimmy, et al. “Crystallization of Feline Coronavirus M
pro With GC376 Reveals Mechanism of Inhibition.”
Frontiers in Chemistry, vol. 10, 2022, p. 852210,
https://doi.org/10.3389/fchem.2022.852210.
[3] Takahashi, Daisuke, et al. “Structural and Inhibitor Studies of Norovirus 3C-like Proteases.”
Virus Research, 178 2, 2013, p. Pages 437-444,
https://doi.org/10.1016/j.virusres.2013.09.008.
[4] Cáceres, C Joaquín, et al. “Efficacy of GC-376 against SARS-CoV-2 Virus Infection in the K18 hACE2 Transgenic Mouse Model.”
bioRxiv : The Preprint Server for Biology, 2021,
https://doi.org/10.1101/2021.01.27.428428.